// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

Adherence To Hydroxychloroquine as Assessed by Measurements of Drug and Metabolite Blood Levels in An International Prospective Study of Sle Patients in Flare

N. Costedoat-Chalumeau - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Influences of Hydroxychloroquine Use on The Risk of Cancers in Patients with Sjogren's Syndrome: Propensity Score Matched Landmark Analysis

T.-T. Chuang - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Sjogren's syndrome

Hydroxychloroquine

Medication Impact on The Risk of Incident Diabetes Mellitus in Patients with Rheumatoid Arthritis: Hydroxychloroquine and Abatacept Protect while Glucocorticoids and Statins Worsen

G. Ozen - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

Hydroxychloroquine

Cyclosporine in Resistant Systemic Jia - A Cheaper Alternative To Biologics for Developing Countries

P.P. Giri - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

RANKL, OPG and OSCAR but Not Dkk-1 Predict Radiographic Progression in An Inception Cohort of Seropositive Rheumatoid Arthritis (RA) Treated-To-Target with Combination Conventional DMARD Therapy

M.D. Wechalekar - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Hydroxychloroquine Sensitizes Chronic Myeloid Cell to 92T Cell Mediated Lysis Independent of Autophagy

Yanmin Zhao - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

TAPERING DMARDS IN THE TREACH TRIAL FLARE RATES, SUSTAINED REMISSION AND RADIOLOGICAL PROGRESSION

T. Kuijper - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

RAPID AND SUSTAINED REMISSION IN EARLY RHEUMATOID ARTHRITIS (RA) TREATED TO TARGET WITH TOCILIZUMAB, METHOTREXATE, OR THEIR COMBINATION: THE U-ACT-EARLY STRATEGY STUDY

J.W. Bijlsma - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

HYDROXYCHLOROQUINE BLOOD LEVELS IN SLE: CLARIFYING DOSING CONTROVERSIES AND IMPROVING ADHERENCE

L.J. Durcan - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

IMPACT OF HYDROXYCHLOROQUINE TREATMENT ON PREGNANCY OUTCOME IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

S. Sciascia - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

EULAR RECOMMENDATIONS FOR Women's HEALTH AND THE MANAGEMENT OF FAMILY PLANNING, ASSISTED REPRODUCTION, PREGNANCY, AND MENOPAUSE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND/OR THE ANTIPHOSPHOLIPID SYNDROME

L. Andreoli - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

DETERMINANTS OF SURVIVAL OF FETUSES WITH AUTOIMMUNE CONGENITAL HEART BLOCK AND FACTORS ASSOCIATED WITH NEONATAL AND LATE-ONSET DILATED CARDIOMYOPATHY: 214 CASES FROM THE FRENCH REGISTRY OF NEONATAL LUPUS

K. Levesque - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune congenital heart block

Hydroxychloroquine

PRESENCE OF AN INTERFERON SIGNATURE IN ANTI-NUCLEAR ANTIBODY POSITIVE INDIVIDUALS PRIOR TO THE ONSET OF SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE

J. Wither - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EFFECT OF HYDROXYCHLOROQUINE ON DISEASE ACTIVITY AND REGULATION OF THE IMMUNE SYSTEM IN SYSTEMIC LUPUS ERYTHEMATOSUS

S.M. Monzavi - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

SCREENING FOR REVERSIBLE HYDROXYCHLOROQUINE-RELATED OCULAR TOXICITY USING AN AMSLER GRID

S. Banerjee - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

NON-ADHERENCE TO DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN THE FIRST YEAR AFTER DIAGNOSIS: COMPARING THREE ADHERENCE MEASURES IN EARLY ARTHRITIS PATIENTS

A. Pasma - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Hydroxychloroquine

SARCODOSIS: OSTEOARTICULAR INVOLVEMEMT- 57 CASES -

K. Echchilali - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Spondyloarthritis

Hydroxychloroquine

BASELINE CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS STARTING CERTOLIZUMAB PEGOL THERAPY AND GLUCOCORTICOID PRESCRIPTION IN THE ECLAIR STUDY IN 20122013

A. Saraux - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

Hydroxychloroquine

A RETROSPECTIVE ANALYSIS ON PREDICTORS OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUG INITIATION AMONG A COHORT OF PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS

M.M. Bonafede - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

OCULAR TOXICITY OF CHLOROQUINE/HYDROXYCHLOROQUINE: A CASE SERIES OF 12 PATIENTS FROM TERTIARY RHEUMATOLOGY REFERRAL INSTITUTE FROM SOUTH INDIA

A.N. Ramakrishnam - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved